Mutual Funds that own iBio Inc.
Vanguard Extended Market Index Fund
87,762
0.5%
100
0%
07/31/2018
Vanguard Total Stock Market Index Fund
62,933
0.36%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
30,230
0.17%
0
0%
07/31/2018
Vanguard Institutional Total Stock Market Index Fund
17,710
0.1%
0
0%
07/31/2018
Vanguard Balanced Index Fund
7,191
0.04%
0
0%
07/31/2018
iShares Core S&P Total US Stock Market ETF
4,262
0.02%
0
0%
09/06/2018
Fidelity Spartan Total Market Index Fund
4,036
0.02%
0
0%
07/31/2018
BlackRock Master Extended Market Index Series
2,102
0.01%
0
0%
01/31/2018
Vanguard Invt. Fds. ICVC - US Equity Index Fund
984
0.01%
-1
0%
06/30/2018
Vanguard Total Stock Market Index Trust
0
0%
-2,960
0%
07/31/2018
| Address |
600 Madison Avenue
New York New York 10022
United States
|
|
Employees
|
- |
| Website |
http://www.ibioinc.com |
| Updated |
07/08/2019 |
| iBio, Inc. operates as a biotechnology company, which focuses on using its proprietary technologies and production facilities to provide product development and manufacturing services to clients, collaborators, and third-party customers as well as developing and commercializing its own product candidates. It operates through the iBio, Inc. and iBio CDMO business segments. The iBio CDMO segment is a subsidiary of the company, which develops and manufactures plant-made pharmaceuticals. |
